-
2
-
-
0031826041
-
New aerosol drug delivery systems for the treatment of immune-mediated pulmonary diseases
-
Waldrep J.C. New aerosol drug delivery systems for the treatment of immune-mediated pulmonary diseases. Drugs Today. 34:(6):1998;549-561.
-
(1998)
Drugs Today
, vol.34
, Issue.6
, pp. 549-561
-
-
Waldrep, J.C.1
-
3
-
-
0027234994
-
Liposomes for drug delivery to the respiratory tract
-
Taylor K.M.G., Farr S.J. Liposomes for drug delivery to the respiratory tract. Drug Dev. Indust. Pharm. 19:1993;123-142.
-
(1993)
Drug Dev. Indust. Pharm.
, vol.19
, pp. 123-142
-
-
Taylor, K.M.G.1
Farr, S.J.2
-
4
-
-
0021276753
-
Liposomes as drug carriers in cancer chemotherapy
-
Weinstein J.N., Leserman L.D. Liposomes as drug carriers in cancer chemotherapy. Pharmacol. Ther. 24:1984;207-233.
-
(1984)
Pharmacol. Ther.
, vol.24
, pp. 207-233
-
-
Weinstein, J.N.1
Leserman, L.D.2
-
5
-
-
0026785415
-
Liposome aerosols
-
Schreier H. Liposome aerosols. J. Liposome Res. 2:1992;145-184.
-
(1992)
J. Liposome Res.
, vol.2
, pp. 145-184
-
-
Schreier, H.1
-
6
-
-
0025779134
-
Aerosol and intraperitoneal administration of ribavarin and ribavarin triacetate: Pharamcokinetics and protection of mice against intracerebral infection with influenza A/WSN virus
-
Gilbert B.E., Wyde P.R., Wilson S.Z., Robins R.K. Aerosol and intraperitoneal administration of ribavarin and ribavarin triacetate: pharamcokinetics and protection of mice against intracerebral infection with influenza A/WSN virus. Antimicrob. Agents Chemother. 35:(7):1991;1448-1453.
-
(1991)
Antimicrob. Agents Chemother.
, vol.35
, Issue.7
, pp. 1448-1453
-
-
Gilbert, B.E.1
Wyde, P.R.2
Wilson, S.Z.3
Robins, R.K.4
-
8
-
-
0032924188
-
Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers
-
Saari M., Vidgren M.T., Koskinen M.O., Turjanmaa V.H.M., Neiminen M.M. Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. Int. J. Pharm. 188:1999;1-9.
-
(1999)
Int. J. Pharm.
, vol.188
, pp. 1-9
-
-
Saari, M.1
Vidgren, M.T.2
Koskinen, M.O.3
Turjanmaa, V.H.M.4
Neiminen, M.M.5
-
9
-
-
0034758170
-
In vitro delivery and regional airway surface liquid concentration of a liposomal cationic peptide
-
Lange C.F., Hancock R.E.W., Samuel J., Finlay W.H. In vitro delivery and regional airway surface liquid concentration of a liposomal cationic peptide. J. Pharm. Sci. 90:2001;1647-1657.
-
(2001)
J. Pharm. Sci.
, vol.90
, pp. 1647-1657
-
-
Lange, C.F.1
Hancock, R.E.W.2
Samuel, J.3
Finlay, W.H.4
-
10
-
-
0025911331
-
Nebulization of liposomes. II. The effects of size and modeling of solute release profiles
-
Niven R.W., Speer M., Schreier H. Nebulization of liposomes. II. The effects of size and modeling of solute release profiles. Pharm. Res. 8:1991;217-221.
-
(1991)
Pharm. Res.
, vol.8
, pp. 217-221
-
-
Niven, R.W.1
Speer, M.2
Schreier, H.3
-
11
-
-
0026513264
-
Nebulization of liposomes. III. The effects of operating conditions and local environment
-
Niven R.W., Carvajal M.A., Schreier H. Nebulization of liposomes. III. The effects of operating conditions and local environment. Pharm. Res. 9:1992;515-520.
-
(1992)
Pharm. Res.
, vol.9
, pp. 515-520
-
-
Niven, R.W.1
Carvajal, M.A.2
Schreier, H.3
-
12
-
-
0025245057
-
Nebulization of liposomes. I. Effects of lipid compositions
-
Niven R.W., Schreier H. Nebulization of liposomes. I. Effects of lipid compositions. Pharm. Res. 7:1990;1127-1133.
-
(1990)
Pharm. Res.
, vol.7
, pp. 1127-1133
-
-
Niven, R.W.1
Schreier, H.2
-
13
-
-
0035857723
-
Nebulization of rehydrated freeze-dried beclomethasone dipropionate liposomes
-
Darwis Y., Kellaway I.W. Nebulization of rehydrated freeze-dried beclomethasone dipropionate liposomes. Int. J. Pharm. 215:2001;113-121.
-
(2001)
Int. J. Pharm.
, vol.215
, pp. 113-121
-
-
Darwis, Y.1
Kellaway, I.W.2
-
14
-
-
0036167306
-
A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling
-
Desai T.R., Wong J.P., Hancock R.E.W., Finlay W.H. A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling. J. Pharm. Sci. 91:2002;482-491.
-
(2002)
J. Pharm. Sci.
, vol.91
, pp. 482-491
-
-
Desai, T.R.1
Wong, J.P.2
Hancock, R.E.W.3
Finlay, W.H.4
-
15
-
-
0031913754
-
The effect of jet-milling on lyophilized liposomes
-
Mobley W.C. The effect of jet-milling on lyophilized liposomes. Pharm. Res. 15:1998;149-152.
-
(1998)
Pharm. Res.
, vol.15
, pp. 149-152
-
-
Mobley, W.C.1
-
16
-
-
0033003473
-
Biological properties of structurally related α-helical cationic antimicrobial peptide
-
Scott M.G., Yan H., Hancock R.E.W. Biological properties of structurally related α-helical cationic antimicrobial peptide. Infect. Immun. 67:1999;2005-2009.
-
(1999)
Infect. Immun.
, vol.67
, pp. 2005-2009
-
-
Scott, M.G.1
Yan, H.2
Hancock, R.E.W.3
-
17
-
-
0032102783
-
Regional lung deposition of nebulized liposome encapsulated ciprofloxacin
-
Finlay W.H., Wong J.P. Regional lung deposition of nebulized liposome encapsulated ciprofloxacin. Int. J. Pharm. 167:1998;121-127.
-
(1998)
Int. J. Pharm.
, vol.167
, pp. 121-127
-
-
Finlay, W.H.1
Wong, J.P.2
-
19
-
-
0032890101
-
Undersizing of droplets from a vented nebulizer caused by aerosol heating during transit through an Anderson impactor
-
Finlay W.H., Stapleton K.W. Undersizing of droplets from a vented nebulizer caused by aerosol heating during transit through an Anderson impactor. J. Aerosol Sci. 30:1999;105-109.
-
(1999)
J. Aerosol Sci.
, vol.30
, pp. 105-109
-
-
Finlay, W.H.1
Stapleton, K.W.2
-
20
-
-
0029587238
-
The effect of ambient relative humidity on regional dosages delivered by a jet nebulizer
-
Prokop R.M., Finlay W.H., Stapleton K.W., Zuberbuhler P. The effect of ambient relative humidity on regional dosages delivered by a jet nebulizer. J. Aerosol Med. 8:1995;363-372.
-
(1995)
J. Aerosol Med.
, vol.8
, pp. 363-372
-
-
Prokop, R.M.1
Finlay, W.H.2
Stapleton, K.W.3
Zuberbuhler, P.4
-
21
-
-
0031389997
-
Predicting regional lung dosage of a nebulized suspension: Pulmicort (budesonide)
-
Finlay W.H., Stapleton K.W., Zuberbuhler P. Predicting regional lung dosage of a nebulized suspension: Pulmicort (budesonide). Part. Sci. Technol. 15:1997;243-251.
-
(1997)
Part. Sci. Technol.
, vol.15
, pp. 243-251
-
-
Finlay, W.H.1
Stapleton, K.W.2
Zuberbuhler, P.3
-
22
-
-
0015935440
-
The effect of charge and cholesterol on the size and thickness of phospholipid vesicles
-
Johnson S.M. The effect of charge and cholesterol on the size and thickness of phospholipid vesicles. Biochim. Biophys. Acta. 307:1973;27-41.
-
(1973)
Biochim. Biophys. Acta
, vol.307
, pp. 27-41
-
-
Johnson, S.M.1
|